Results 1 to 10 of about 710,088 (156)

Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery [PDF]

open access: yesAntibiotics, 2023
Fragment-based lead discovery (FBLD) is a powerful application for developing ligands as modulators of disease targets. This approach strategy involves identification of interactions between low-molecular weight compounds (100–300 Da) and their putative ...
Monika I. Konaklieva, Balbina J. Plotkin
doaj   +4 more sources

Integration of Lead Discovery Tactics and the Evolution of the Lead Discovery Toolbox

open access: yesSLAS Discovery, 2018
There has been much debate around the success rates of various screening strategies to identify starting points for drug discovery. Although high-throughput target-based and phenotypic screening has been the focus of this debate, techniques such as fragment screening, virtual screening, and DNA-encoded library screening are also increasingly reported ...
Melanie Leveridge   +2 more
exaly   +3 more sources

In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery

open access: yesFrontiers in Chemistry, 2020
Fragment-based drug (or lead) discovery (FBDD or FBLD) has developed in the last two decades to become a successful key technology in the pharmaceutical industry for early stage drug discovery and development.
Lauro Ribeiro de Souza Neto   +9 more
doaj   +3 more sources

Multiparameter ranking of carbazoles for anti-trypanosome lead discovery [PDF]

open access: yesFrontiers in Drug Discovery
The criteria for the progression of hits in the discovery of leads for human African trypanosomiasis (HAT), a neglected disease caused by the microbial eukaryote Trypanosoma brucei, are not standardized. Hits are advanced upon meeting thresholds for drug-
Amrita Sharma   +5 more
doaj   +2 more sources

Process of Fragment-Based Lead Discovery—A Perspective from NMR [PDF]

open access: yesMolecules, 2016
Fragment-based lead discovery (FBLD) has proven fruitful during the past two decades for a variety of targets, even challenging protein–protein interaction (PPI) systems.
Rongsheng Ma   +3 more
doaj   +2 more sources

Virtual Screening in Lead Discovery: A Viewpoint [PDF]

open access: yesMolecules, 2002
Virtual screening (VS) methods have emerged as an adaptive response to massive throughput synthesis and screening technologies. Based on the structure-permeability paradigm, the Lipinski rule of five has become a standard property filtering protocol for ...
Tudor Ionel Oprea
doaj   +2 more sources

1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery [PDF]

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2019
Claire Raingeval   +2 more
exaly   +2 more sources

BRET measurement on CCD camera-based microtiter plate readers

open access: yesSLAS Discovery, 2022
NanoBRET assays, which utilize bioluminescence energy resonance transfer (BRET), have been widely adopted in drug discovery for measuring both protein-protein interactions and drug target engagement. While the EnVision and other traditional well-scanning
Kelvin F. Cho   +2 more
doaj   +1 more source

Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins

open access: yesCommunications Biology, 2021
Malvezzi et al. discuss the impact of BRD4 phosphorylation on the formation of dimers and identify the key residues necessary for this dimerization. They also discuss the differential role of monovalent and bivalents bromodomain inhibitors regarding the ...
Francesca Malvezzi   +9 more
doaj   +1 more source

Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic models

open access: yesmAbs, 2020
The development of antibody therapeutics relies on animal models that accurately recapitulate disease biology. Syngeneic mouse models are increasingly used with new molecules to capture the biology of complex cancers and disease states, and to provide ...
Feng Wang   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy